Keywords
Lymphocytes
Hematopoietic stem cell transplantation
Mucositis
Graft vs host disease
How to Cite
Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment for many diseases; however, it can induce complications such as Oral Mucositis (OM) and Graft-versus- Host Disease (GVHD). The neutrophil-lymphocyte ratio (NLR) is a peripheral biomarker of systemic inflammation and an independent prognostic factor for several inflammatory diseases. Aim: This study aimed to evaluate the association of NLR with OM and GVHD in patients undergoing allogeneic HSCT. Methods: Patients who underwent allogeneic HSCT at the Bone Marrow Transplant Service of the Hospital de Clínicas Complex of the Federal University of Paraná were included in the study. Socio-demographic data and blood counts were collected from patients’ medical records. The NLR was calculated and associated with OM and GVHD. Results: 45 patients were included in the study. Although NLR was higher in patients with OM and oral GVHD, no statistical difference was observed, and no relationship between OM and GVHD with NLR could be stated. Conclusion: Although both OM and GVHD are associated with an inflammatory response as well as the immune system, it was not associated with NLR. Further investigation considering other variables related to HSCT might find possible associations, as it could favor patient management and prevention.
References
Cavalcanti LG, Araújo RLF, Bonfim C, Torres-Pereira CC. Oral manifestations compatible with chronic graft-versus-host disease in patients with fanconi anemia. Biol Blood Marrow Transplant. 2015 Feb;21(2):275-80. doi: 10.1016/j.bbmt.2014.10.009.
McManigle W, Youssef A, Sarantopoulos S. B cells in chronic graft-versus-host disease. Human Immunol. 2019 Jun;80(3):393-99. doi: 10.1016/j.humimm.2019.03.003 .
Kuten-Shorrer M, Woo SB, Treister NS. Oral graft-versus-host disease. Dent Clin North Am. 2014 Apr;58(2):351-68. doi: 10.1016/j.cden.2013.12.007.
Armitage JO. Bone marrow transplantation. N Engl J Med. 1994 Mar;330(12):827-38. doi: 10.1056/NEJM199403243301206.
Amadori F, Bardellini E, Conti G, Pedrini N, Schumacher RF, Majorana A. Low-level laser therapy for treatment of chemotherapy-induced oral mucositis in childhood: a randomized double-blind controlled study. Lasers Med Sci. 2016 Aug;31(6):1231-6. doi: 10.1007/s10103-016-1975-y.
Grkovic L, Baird K, Steinberg SM, Williams KM, Pulanic D, Cowen EW, et al. Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia. 2012 Apr;26(4):633-43. doi: 10.1038/leu.2011.254.
Albuquerque R, Khan Z, Poveda A, Higham J, Richards A, Monteiro L, et al. Management of oral Graft versus Host Disease with topical agents: a systematic review. Med Oral Patol Oral Cir Bucal. 2016 Jan;21(1):e72-81. doi: 10.4317/medoral.20968.
Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, et al. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015 Apr;94(4):547-54. doi: 10.1177/0022034515570942.
Inamoto Y. [2018 update on chronic graft-versus-host disease]. Rinsho Ketsueki. 2018;59(10):2300-6. Japanese. doi: 10.11406/rinketsu.59.2300.
Fall-Dickson JM, Pavletic SZ, Mays JW, Schubert MM. Oral complications of chronic graft-versus-host disease. J Natl Cancer Inst Monogr. 2019 Aug;2019(53):lgz007. doi: 10.1093/jncimonographs/lgz007.
Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14.
Abayli B, Gençdal G, Değirmencioğlu S. Correlation between neutrophil/lymphocyte ratio and Ranson score in acute pancreatitis. J Clin Lab Anal. 2018 Jul;32(6):e22437. doi: 10.1002/jcla.22437.
Derin S, Erdogan S, Sahan M, Topal H, Sozen H. Neutrophil–lymphocyte ratio in patients with adenoidectomy. J Clin Diagn Res. 2016 Mar;10(3):MC03–5. doi: 10.7860/JCDR/2016/16549.7360.
Kuzucu I, Güler I, Kum RO, Baklaci D, Özcan M. Increased neutrophil lymphocyte ratio and platelet lymphocyte ratio in malignant parotid tumors. Braz J Otorhinolaryngol. 2020 Jan-Feb;86(1):105-10. doi: 10.1016/j.bjorl.2019.02.009.
Stefaniuk P, Szymczyk A, Podhorecka M. The neutrophil to lymphocyte and lymphocyte to monocyte ratios as new prognostic factors in hematological malignancies – a narrative review. Cancer Manag Res. 2020 Apr;12:2961-77. doi: 10.2147/CMAR.S245928.
Solmaz Medeni S, Acar C, Olgun A, Acar A, Seyhanlı A, Taskıran E, et al. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation? Clin Transplant. 2018 Sep;32(9):e13359. doi: 10.1111/ctr.13359.
Shi G, Zhao JW, Ming L. [Clinical significance of peripheral blood neutrophil-lymphocyte ratio and platelet- lymphocyte ratio in patients with asthma]. Nan Fang Yi Ke Da Xue Bao. 2017 Jan;37(1):84-8. Chinese. doi: 10.3969/j.issn.1673-4254.2017.01.15.
Zhang B, Du W, Gan K, Fang Q, Zhan X. Significance of the neutrophil-to-lymphocyte ratio in young patients with oral squamous cell carcinoma. Cancer Manag Res. 2019 Aug;11:7597-603. doi: 10.2147/CMAR.S211847.
Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics. J Dermatol. 2017 Oct;44(10):1112-21. doi: 10.1111/1346-8138.13875.
Erre GL, Paliogiannis P, Castagna F, Mangoni AA, Carru C, Passiu G, et al. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis. Eur J Clin Invest. 2019 Jan;49(1):e13037. doi: 10.1111/eci.13037.
Rifaioglu EN, Şen BB, Ekiz Ö, Dogramaci AC. Neutrophil to lymphocyte ratio in Behçet's disease as a marker of disease activity. Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(4):65-7. doi: 10.15570/actaapa.2014.16.
Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504 .
Zeng Z, Wang C, Wang B, Wang N, Yang Y, Guo S, et al. Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression of autoimmune encephalitis. Neurosci Lett. 2019 Feb 16;694:129-135. doi: 10.1016/j.neulet.2018.12.003.
Elad S. The MASCC/ISOO Mucositis Guidelines 2019: the second set of articles and future directions. Support Care Cancer. 2020 May;28(5):2445-7. doi: 10.1007/s00520-019-05153-w .
Pavletic SZ, Vogelsang GB, Lee SJ. 2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series. Biol Blood Marrow Transplant. 2015 Mar;21(3):387-8. doi: 10.1016/j.bbmt.2014.12.035.
Amonchaisakda N, Aiempanakit K. Clinical characteristics, mortality, and prognostic factors for bullous pemphigoid in a Thai population. Medicine (Baltimore). 2020 Oct;99(43):e22850. doi: 10.1097/MD.0000000000022850.
Forget P, Khalifa C, Defour JP, Latinne D, Pel MCV, Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017 Jan;10(1):12. doi: 10.1186/s13104-016-2335-5.
Volpato LE, Silva TC, Oliveira TM, Sakai VT, Machado MA. Radiation therapy and chemotherapy-induced oral mucositis. Braz J Otorhinolaryngol. 2007 Jul-Aug;73(4):562-8. doi: 10.1016/s1808-8694(15)30110-5.
Carlens S, Ringdén O, Remberger M, Lönnqvist B, Hägglund H, Klaesson S, et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant. 1998 Oct;22(8):755-61. doi: 10.1038/sj.bmt.1701423.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Isabella Christina Costa Quadras, Fernanda Aparecida Stresser, Stephanie von Stein Cubas Warnavin, Vaneuza Araújo Moreira Funke, Rafael Zancan Mobile, Juliana Lucena Schussel
Downloads
